Target Name: DUSP16
NCBI ID: G80824
Other Name(s): MGC129702 | MAP kinase phosphatase 7 | KIAA1700 | MKP-7 | FLJ36298 | MAPK phosphatase-7 | FLJ40991 | MGC129701 | MKP7 | Dual specificity phosphatase 16 | DUS16_HUMAN | mitogen-activated protein kinase phosphatase 7 | Mitogen-activated protein kinase phosphatase 7 | dual specificity phosphatase 16 | Dual specificity protein phosphatase 16

DUSP16: A Protein Regulating Pancreatic Beta Cells and Cancer Development

DUSP16 (MGC129702) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the DUSP gene family, which is known for its role in cell signaling and development.

One of the functions of DUSP16 is to regulate the growth and differentiation of pancreatic beta cells, which are responsible for producing insulin to regulate blood sugar levels. beta cells are a critical component of the pancreas, and any damage or dysfunction in these cells can lead to a range of insulin-related diseases, including type 1 diabetes.

In addition to its role in pancreatic beta cell function, DUSP16 has also been shown to play a key role in the development and progression of cancer. It has been found to be highly expressed in various types of cancer, including pancreatic, breast, and ovarian cancer.

Furthermore, DUSP16 has also been shown to be involved in the regulation of inflammation and immune responses. It has been found to be expressed in various immune cells, including dendritic cells, macrophages, and T cells. In addition, DUSP16 has been shown to play a key role in the regulation of immune cell function and the production of antibodies.

DUSP16 is also known as MGC129702 because it is a potential drug target for a company called Moderna Therapeutics. The company has developed a monoclonal antibody called DUSP-160, which is designed to block the function of DUSP16 and prevent it from regulating the growth and differentiation of pancreatic beta cells.

In addition to its potential use as a drug target, DUSP16 also has potential as a biomarker for certain diseases. For example, it has been shown to be a potential biomarker for pancreatic cancer, as it has been found to be expressed in the majority of pancreatic cancer samples. In addition, DUSP16 has also been shown to be a potential biomarker for breast and ovarian cancer, as it has been found to be expressed in the majority of breast and ovarian cancer samples.

Overall, DUSP16 is a protein that has important roles in various physiological processes in the body. Its function as a drug target and biomarker make it an attractive target for further research and development. Further studies are needed to fully understand its role in disease and its potential as a drug and biomarker.

Protein Name: Dual Specificity Phosphatase 16

Functions: Dual specificity protein phosphatase involved in the inactivation of MAP kinases. Dephosphorylates MAPK10 bound to ARRB2

More Common Targets

DUSP18 | DUSP19 | DUSP2 | DUSP21 | DUSP22 | DUSP23 | DUSP26 | DUSP28 | DUSP29 | DUSP3 | DUSP4 | DUSP5 | DUSP5P1 | DUSP6 | DUSP7 | DUSP8 | DUSP8P5 | DUSP9 | DUT | DUTP6 | DUX1 | DUX3 | DUX4 | DUX4L1 | DUX4L13 | DUX4L16 | DUX4L18 | DUX4L19 | DUX4L2 | DUX4L20 | DUX4L23 | DUX4L3 | DUX4L37 | DUX4L4 | DUX4L5 | DUX4L6 | DUX4L7 | DUX4L8 | DUX4L9 | DUXA | DUXAP10 | DUXAP3 | DUXAP8 | DUXAP9 | DVL1 | DVL2 | DVL3 | DXO | DYDC1 | DYDC2 | DYM | Dynactin | DYNAP | DYNC1H1 | DYNC1I1 | DYNC1I2 | DYNC1LI1 | DYNC1LI2 | DYNC2H1 | DYNC2I1 | DYNC2I2 | DYNC2LI1 | DYNLL1 | DYNLL2 | DYNLRB1 | DYNLRB2 | DYNLRB2-AS1 | DYNLT1 | DYNLT2 | DYNLT2B | DYNLT3 | DYNLT4 | DYNLT5 | DYRK1A | DYRK1B | DYRK2 | DYRK3 | DYRK4 | DYSF | Dystrophin-Associated Glycoprotein Complex | DYTN | DZANK1 | DZIP1 | DZIP1L | DZIP3 | E2F Transcription Factor | E2F-6 complex | E2F1 | E2F2 | E2F3 | E2F4 | E2F5 | E2F6 | E2F6P4 | E2F7 | E2F8 | E3 ubiquitin-protein ligase | E4F1 | EAF1 | EAF2